Evidence map›Paper›PMID 42512350›Full record

ReviewCancers2026

Prognostic Impact of Baseline Circulating Tumor DNA (ctDNA) in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Maen Abdelrahim, Abdullah Esmail, Minhal Zaidi, Nour Mustafa, Yazan Hamdaneh, Zaid Alabed, Saifudeen Abdelrahim, Ebtesam Al-Najjar, Hikmat Abdel-Razeq, Asem Mansour

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maen AbdelrahimSection of GI Oncology, Department of Medicine, Houston Methodist Cancer Center, Houston, TX 77030, USA.
Abdullah EsmailSection of GI Oncology, Department of Medicine, Houston Methodist Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-2337-8351
Minhal ZaidiSection of GI Oncology, Department of Medicine, Houston Methodist Cancer Center, Houston, TX 77030, USA.
Nour MustafaFaculty of Medicine, The University of Jordan, Amman 11942, Jordan.
Yazan HamdanehFaculty of Medicine, The University of Jordan, Amman 11942, Jordan.
Zaid AlabedFaculty of Medicine, The University of Jordan, Amman 11942, Jordan.
Saifudeen AbdelrahimSection of GI Oncology, Department of Medicine, Houston Methodist Cancer Center, Houston, TX 77030, USA.
Ebtesam Al-NajjarFaculty of Medicine, The University of Jordan, Amman 11942, Jordan.
Hikmat Abdel-RazeqDepartment of Internal Medicine, King Hussein Cancer Center, Amman 11941, Jordan.
Asem MansourDepartment of Radiology, King Hussein Cancer Center, Amman 11941, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

circulating tumor DNAmeta-analysisoverall survivalpancreatic ductal adenocarcinomaprogression-free survival

Identifiers

PMID42512350
PMCPMC13407315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.